Skip Navigation

COVID-19 Update

Due to interest in the COVID-19 vaccines, we are experiencing an extremely high call volume. Please understand that our phone lines must be clear for urgent medical care needs. We are unable to accept phone calls to schedule COVID-19 vaccinations at this time. When this changes, we will update this website. Our vaccine supply remains limited. Read all COVID-19 Vaccine Information.

Patient Care Options | Visitor Guidelines | Coronavirus Information | Self-Checker | Get Email Alerts

Search Menu
Gynecology & Obstetrics

In This Section      

Conditions We Treat: Gestational Trophoblastic Disease

Gestational trophoblastic disease (GTD) is the name given to a group of tumors associated with abnormal pregnancies. Some types of GTD tumors are cancerous, but most are noncancerous. 

Gestational Trophoblastic Disease: What You Need to Know

Woman working on computer
  • Gestational trophoblastic disease is the name of a group of rare tumors that develop during pregnancy.
  • GTD tumors can be malignant (cancerous) or benign (noncancerous).
  • GTD affects about one in every 1,000 pregnant women in the U.S.
  • Many women treated for GTD go on to have normal, healthy pregnancies in the future

Patient Resources

Request an Appointment


Why choose Johns Hopkins for treatment of gestational trophoblastic disease?

radiologist next to an MRI

Our Surgical Expertise

Our expertise in minimally invasive gynecologic surgery means our patients have faster recovery times, fewer complications and less pain.

Drs. Armstrong, Shih and Sinno in the lab

Our Research

The research of our gynecologic pathologists has led to a better understanding of the molecular changes involved in GTD tumors. This information assists our patient care team in determining the appropriate treatment and follow-up regimens. Each patient receives a personalized care plan tailored to the molecular makeup of his or her case of GTD.